Table 1 Comparative characteristics of patients with lymphocytic colitis and collagenous colitis
From: Cancer risk in microscopic colitis: a retrospective cohort study
Characteristic | Lymphocytic colitis | Microscopic colitis | p-value |
|---|---|---|---|
Mean age at diagnosis (in years) (SD) | 59.5 (18.1) | 62.5 (13.1) | 0.15 |
Gender | 0.13 | ||
Female | 73% | 82% | |
Male | 27% | 18% | |
Race / Ethnicity | 0.50 | ||
White | 93% | 95% | |
Non-white | 7% | 5% | |
Ever smoking | 47% | 43% | 0.58 |
Aspirin use | 37% | 33% | 0.56 |
NSAID use | 12% | 23% | 0.03 |
Treatment for MC | |||
Budesonide | 45% | 55% | 0.12 |
Prednisone | 7% | 13% | 0.11 |
Cholestyramine | 12% | 19% | 0.15 |
Immunosuppressant | 9% | 13% | 0.26 |
Mean number of episodes (SD) | 1.77 (1.68) | 1.40 (1.25) | 0.059 |